No results for ‘’
Medicamen Biotech Ltd
NSE: MEDICAMEQ BSE: 531146
₹315
(1.01%)
Tue, 29 Sept 2026, 01:12 pm
Market Cap (in Cr)426.41
PE Ratio38.46
Dividend0.30
Health Technology
Pharmaceuticals: Major
24.5KCompany History
1993
- MBL was incorporated as a public limited company under the Companies Act, 1956.
1994
- The company obtained the certificate of commencement of business.
2010
- The Company has recommended a final dividend of Rs. 0.75 per equity share.
- The Company appointed Mr. B.K.Gupta as Managing Director.
2011
- The Company gets ANVISA.Brazil approval for Non Beta Lactum solid Tablets and Coated tablets manufactured at its Plant situated at SP 1192,A & B, Phase 4, Bhiwadi - 301019, Rajasthan.
2013
- Ms. Harshita Sharma has been appointed as Additional Director of the company.
2016
- Shivalik Rasayan Ltd take controlling stake of Medicamen Biotech Ltd.
2019
- FABD(Philippines), CECMED(Cuba)-Bhiwadi FDF Plant.
2020
- Global API Facility started Dahej API Plant.
2021
- Operations started Haridwar formulation Unit II(FDF).
2023
- Medicamen Biotech Gains On Successful Anda Filing For Bortezomib Injections.
2024
- Medicamen Biotech's Bhiwadi Manufacturing Facility Secures EU GMP Approval from Greece.
- Medicamen Biotech's Sterile injectable Facility Received USFDA Approval.